Eva Rohde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eva Rohde has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Agnieszka J. Szczepek
Department of Otorhinolaryngology, Head and Neck Surgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany
1 shared publication - Anja Maria Giesemann
Department of Diagnostic and Interventional Neuroradiology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany
1 shared publication - Arianna Di Stadio
Department of Life Science, Health and Health Professions, Link University, Rome, Italy
1 shared publication - Athanasia Warnecke
Department of Otorhinolaryngology—Head and Neck Surgery, Hannover Medical School, 30625 Hanover, Germany
1 shared publication - Hinrich Staecker
University of Kansas School of Medicine, Department of Otolaryngology-Head and Neck Surgery, Kansas City, United States of America
1 shared publication - Ingeborg Hochmair
MED-EL Medical Electronics, Fürstenweg 77a, 6020 Innsbruck, Austria
1 shared publication
Latest Publications
- Open Access
- 15 December 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (24) , 7455
Extracellular Vesicles in Inner Ear Therapies—Pathophysiological, Manufacturing, and Clinical Considerations
(1) Background: Sensorineural hearing loss is a common and debilitating condition. To date, comprehensive pharmacologic interventions are not available. The complex and diverse molecular pathology that underlies hearing loss may limit our ability to intervene with small molecules. The current review foccusses on the potential for the use of extracellular vesicles in neurotology. (2) Methods: Narrative literature review. (3) Results: Extracellular vesicles provide an opportunity to modulate a wide range of pathologic and physiologic pathways and can be manufactured under GMP conditions allowing for their application in the human inner ear. The role of inflammation in hearing loss with a focus on cochlear implantation is shown. How extracellular vesicles may provide a therapeutic option for complex inflammatory disorders of the inner ear is discussed. Additionally, manufacturing and regulatory issues that need to be addressed to develop EVs as advanced therapy medicinal product for use in the inner ear are outlined. (4) Conclusion: Given the complexities of inner ear injury, novel therapeutics such as extracellular vesicles could provide a means to modulate inflammation, stress pathways and apoptosis in the inner ear.
- 15 December 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (24) , 7455
Open AccessExtracellular Vesicles in Inner Ear Therapies—Pathophysiological, Manufacturing, and Clinical Considerations
(1) Background: Sensorineural hearing loss is a common and debilitating condition. To date, comprehensive pharmacologic interventions are not available. The complex and diverse molecular pathology that underlies hearing loss may limit our ability to intervene with small molecules. The current review foccusses on the potential for the use of extracellular vesicles in neurotology. (2) Methods: Narrative literature review. (3) Results: Extracellular vesicles provide an opportunity to modulate a wide range of pathologic and physiologic pathways and can be manufactured under GMP conditions allowing for their application in the human inner ear. The role of inflammation in hearing loss with a focus on cochlear implantation is shown. How extracellular vesicles may provide a therapeutic option for complex inflammatory disorders of the inner ear is discussed. Additionally, manufacturing and regulatory issues that need to be addressed to develop EVs as advanced therapy medicinal product for use in the inner ear are outlined. (4) Conclusion: Given the complexities of inner ear injury, novel therapeutics such as extracellular vesicles could provide a means to modulate inflammation, stress pathways and apoptosis in the inner ear.